3.60
3.60 (0%)
As of Feb 14, 2025
Third Harmonic Bio, Inc. [THRD]
Source:
Company Overview
Third Harmonic Bio, Inc. is a biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases.
| Country | United States |
| Headquarters | san francisco, california |
| Phone Number | (209) 727-2457 |
| Industry | manufacturing |
| CEO | Natalie Holles |
| Website | thirdharmonicbio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $58.9 |
| Net Income | $45.5 |
| Net Cash | $16 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | 15.9% |
| Profit as % of Stockholder Equity | 16% |
Management Effectiveness
| Return on Equity | 16% |
| Return on Assets | 15.4% |
| Turnover Ratio | |
| EBITA | $58.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $294.6 |
| Total Liabilities | $9.5 |
| Operating Cash Flow | $-34.5 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $50.5 |
